← Back to all trials
Recruiting
NCT05183230
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or Attempt
Conditions: Suicide, Attempted, Suicidal Ideation, Depression
Sex: All
Ages: 50 Years – 90 Years
Healthy volunteers: No
Phase: NA
Enrollment: 115
Sponsor: Weill Medical College of Cornell University
Location: New York Presbyterian Hospital/Weill Cornell Medicine New York New York
Summary
The goal of this project is to test whether WellPATH-PREVENT (a novel, mobile psychosocial intervention) improves a specific aspect of emotion regulation, i.e., cognitive reappraisal ability, and reduces suicide risk in middle-aged and older adults (50-90 years old) who have been discharged after a suicide-related hospitalization (i.e. for suicidal ideation or suicide attempt).
Eligibility Criteria
Inclusion Criteria:
* 50-90 years old
* Diagnosis (based on a modified SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 except: current diagnosis of Psychotic Disorder; diagnosis of Dementia
* Recent hospitalization for suicidal ideation or suicide attempt; at hospital admission, Columbia Suicide Severity Rating Scale (CSSR-S) ≥ 2, "Non-specific Active Suicidal Thoughts."
* We will also include patients on psychotropics and on after-care community psychotherapy.
Exclusion Criteria:
* Current diagnosis of Psychotic Disorders; Diagnosis of Dementia
* Cognitive Impairment (MMSE ≤ 24)
* Acute or severe medical illness (i.e., delirium; decompensated cardiac, liver or kidney failure; major surgery; stroke or myocardial infarction during the three months prior to entry
* Aphasia, sensory problems, and/or inability to speak English.
Source: ClinicalTrials.gov (NCT05183230). StuddyBuddy aggregates publicly available trial information.